Pathstone Holdings LLC Buys 7,412 Shares of Encompass Health Co. (NYSE:EHC)

Pathstone Holdings LLC increased its holdings in Encompass Health Co. (NYSE:EHC - Free Report) by 54.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 21,022 shares of the company's stock after acquiring an additional 7,412 shares during the quarter. Pathstone Holdings LLC's holdings in Encompass Health were worth $2,032,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Dimensional Fund Advisors LP increased its position in Encompass Health by 1.2% during the second quarter. Dimensional Fund Advisors LP now owns 1,819,345 shares of the company's stock worth $156,083,000 after purchasing an additional 22,311 shares during the last quarter. Copeland Capital Management LLC grew its position in shares of Encompass Health by 1.0% during the third quarter. Copeland Capital Management LLC now owns 1,284,550 shares of the company's stock worth $124,139,000 after acquiring an additional 12,433 shares during the last quarter. Thrivent Financial for Lutherans boosted its position in Encompass Health by 26.0% during the 3rd quarter. Thrivent Financial for Lutherans now owns 760,496 shares of the company's stock worth $73,494,000 after acquiring an additional 156,938 shares during the period. Magnetar Financial LLC increased its position in shares of Encompass Health by 1,176.6% during the 2nd quarter. Magnetar Financial LLC now owns 744,836 shares of the company's stock valued at $63,899,000 after purchasing an additional 814,018 shares during the period. Finally, Reinhart Partners LLC. raised its holdings in shares of Encompass Health by 2.4% in the 3rd quarter. Reinhart Partners LLC. now owns 673,040 shares of the company's stock worth $65,043,000 after purchasing an additional 15,550 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have weighed in on EHC shares. KeyCorp upped their price objective on shares of Encompass Health from $115.00 to $117.00 and gave the company an "overweight" rating in a research note on Tuesday, October 29th. Royal Bank of Canada increased their price target on shares of Encompass Health from $105.00 to $110.00 and gave the company an "outperform" rating in a report on Wednesday, October 30th. Barclays raised their target price on Encompass Health from $109.00 to $116.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 29th. UBS Group boosted their price target on shares of Encompass Health from $100.00 to $110.00 and gave the company a "buy" rating in a research report on Wednesday, September 25th. Finally, Stephens restated an "overweight" rating and issued a $105.00 price objective on shares of Encompass Health in a research report on Tuesday, August 6th. Nine investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Buy" and an average target price of $107.11.

Encompass Health Trading Down 0.9 %

Encompass Health stock traded down $0.93 during trading hours on Wednesday, reaching $102.84. 543,892 shares of the company's stock were exchanged, compared to its average volume of 640,786. The firm has a market capitalization of $10.36 billion, a PE ratio of 25.06, a PEG ratio of 1.35 and a beta of 0.88. Encompass Health Co. has a twelve month low of $63.78 and a twelve month high of $104.55. The firm's 50 day simple moving average is $97.28 and its 200 day simple moving average is $90.99. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The firm had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.33 billion. During the same period in the previous year, the firm earned $0.86 EPS. The business's revenue for the quarter was up 11.9% compared to the same quarter last year. Research analysts predict that Encompass Health Co. will post 4.29 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be paid a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.66%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health's dividend payout ratio is presently 16.43%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.